- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05475574
Effekten av att avbryta kontaktförebyggande åtgärder för utökat spektrum av β-laktamas Enterobacteriaceae i en geriatrisk enhet (Ger-SP)
Effekten av att avbryta kontaktförsiktighetsåtgärder för utökat spektrum β-laktamas Enterobacteriaceae (ESBLE) i en geriatrisk enhet: en interventionell prospektiv noninferiority Icke-randomiserad dubbelblind kontrollerad före och efter studie
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study.
The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Healthcare-associated infections (HAIs) are one of the main causes of morbidity and mortality worldwide. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have become microorganisms frequently found in HAIs, which reduces the therapeutic possibilities.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Olfa EZZI, MD
- Telefonnummer: 0033 3 87 17 93 98
- E-post: olfa.ezzi@chr-metz-thionville.fr
Studera Kontakt Backup
- Namn: Mathieu LLORENS, MD
- Telefonnummer: 0033 0033 3 87 55 38 39
- E-post: mathieu.llorens@chr-metz-thionville.fr
Studieorter
-
-
-
Metz, Frankrike, 57085
- Rekrytering
- CHR Metz-Thionville/Hôpital Bel Air
-
Kontakt:
- Azzedine AZZEMOU, MD
- E-post: a.azzemou@chr-metz-thionville.fr
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Adult patient (> 65 years old)
- Patient hospitalized in geriatrics during the study period
- Free and informed consent obtained from the patient (or his trusted person or legal representative) within 48 hours of its admission at the geriatric unit
- Patient affiliated to a social security scheme
Non Inclusion Criteria:
- Patient requiring contact precaution for an indication other than ESBLE (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC) on admission
- Patient under legal protection
- Person deprived of liberty
Exclusion criteria:
- Patient requiring contact precaution for an indication other than ESBL during the patient stay (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC)
- Patient's stay period less than 4 days
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Before discontinuation of contact precautions for ESBLE
Implementation of contact precaution in addition to standard precaution for any patient carrying (infected or colonized) ESBLE |
|
|
Experimentell: After discontinuation of contact precautions for ESBLE
Discontinuation of contact precaution : only standard precaution are implemented for any patient carrying (infected or colonized) ESBLE |
Discontinuation of contact precaution : only standard precaution are implemented for any patient carrying (infected or colonized) ESBLE |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence density of acquired ESBLE
Tidsram: during 6 month period
|
Incidence density of acquired ESBLE in geriatric unit for 1000 days of hospitalization is calculated by dividing the number of acquired ESBLE by the number of days of patients' hospitalization multiplied by 1000 Acquisition of ESBLE is defined by a positive sample in patient on discharge day with a negative sample on admission in geriatric unit A positive sample is defined by the presence of at least one ESBLE on a clinical (infection) or screening (colonization) sample. The hospitalisation number is calculated as the cumulative length of stay of all patients at risk (= negative on admission). |
during 6 month period
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence density of acquired ESBLE by species during 6 month period
Tidsram: during 6 month period
|
Incidence density of acquired ESBLE in geriatric unit by species (E. coli versus non-E. coli) for 1000 days of hospitalization. This is calculated by dividing the number of acquired ESBLE by species by the number of days of patients' hospitalization multiplied by 1000. Acquisition of ESBLE is defined by a positive sample in patient on discharge day with a negative sample on admission in geriatric unit A positive sample is defined by the presence of at least one ESBLE on a clinical (infection) or screening (colonization) sample. The hospitalisation number is calculated as the cumulative length of stay of all patients at risk (= negative on admission). |
during 6 month period
|
|
The rate of compliance with hand hygiene in health care providers
Tidsram: Up to 3 months per health department
|
The evaluation of the compliance with hygiene measures is calculated in health care providers by dividing the number of hand hygiene moments carried out by the number of opportunities multiplied by 100, according to the World Health Organization (WHO) methodology |
Up to 3 months per health department
|
|
Evaluation of the barriers to alcohol-based hand rub in case of non-compliance in health care providers
Tidsram: Up to 3 months per health department
|
The barriers to alcohol-based hand rub are identified in case of non-compliance, using a Pulpe' friction questionnaire (RéPIAS) where professionals are interviewed about their practices in terms of hand hygiene. For each situation, the professional is also asked how important it is for him to perform hand hygiene in each situation listed above, with a slider to be positioned between 0 (not at all important; worse outcome) and 10 (the most important; better outcome). |
Up to 3 months per health department
|
|
The rate of compliance with personal protective equipment
Tidsram: Up to 3 months per health department
|
The rate of compliance with the wearing and removal of personal protective equipment throughout patient care, is observed during care related to the management of excreta (changing, putting on or removing a dish basin, use of a basin washer-disinfector). The rate is calculated by dividing the number of personal protective equipment good caring practices by the number of opportunities multiplied by 100. |
Up to 3 months per health department
|
|
Evaluation of satisfaction related to patient care, by self-questionnaire Hospital anxiety and depression scale (HADS)
Tidsram: on the day of discharge of the geriatric unit, on average on the 11th day
|
The Hospital Anxiety and Depression Scale (HADS) is a 14-item measure designed to assess anxiety and depression symptoms in medical patients, with emphasis on reducing the impact of physical illness on the total score. Items are rated on a 4-point severity scale. The HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Scores of greater than or equal to 11 on either scale indicate a definitive case. |
on the day of discharge of the geriatric unit, on average on the 11th day
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Noel BLETTNER, MD, Mercy Hospital CHR Metz Thionville
- Huvudutredare: Azzeddine AZZEMOU, MD, Bel Air Hospital CHR Metz Thionville
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2021-05-CHRMT
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .